CV - Thromboembolic disorders

Fact Sheets (2)
Guidelines (21)
Drug Sections (13)

CV - Thromboembolic disorders in the News

Ticagrelor approved for NHS use post-MI

The antiplatelet drug ticagrelor (Brilique) can now be prescribed on the NHS to reduce the risk of atherothrombotic events following MI.

Anticoagulant linked to rare calciphylaxis risk

Anticoagulant linked to rare calciphylaxis risk

Calciphylaxis, a rare but serious condition causing vascular calcification and skin necrosis, has been reported in patients taking warfarin.

Ticagrelor approved for long-term treatment following MI

Ticagrelor approved for long-term treatment following MI

The antiplatelet treatment Brilique (ticagrelor) can now be prescribed in adults with a history of MI at least one year previously who are at high risk of a further atherothrombotic event.

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.